A Recent Review on Cancer Nanomedicine

Overview

Journal Cancers (Basel)

Publisher MDPI

Specialty Oncology

Date 2023 May 16

PMID 37190185

Authors

Paras Mani Giri

Anurag Banerjee

Buddhadev Layek

Affiliations

Soon will be listed here.

Abstract

Cancer is one of the most prevalent diseases globally and is the second major cause of death in the United States. Despite the continuous efforts to understand tumor mechanisms and various approaches taken for treatment over decades, no significant improvements have been observed in cancer therapy. Lack of tumor specificity, dose-related toxicity, low bioavailability, and lack of stability of chemotherapeutics are major hindrances to cancer treatment. Nanomedicine has drawn the attention of many researchers due to its potential for tumor-specific delivery while minimizing unwanted side effects. The application of these nanoparticles is not limited to just therapeutic uses; some of them have shown to have extremely promising diagnostic potential. In this review, we describe and compare various types of nanoparticles and their role in advancing cancer treatment. We further highlight various nanoformulations currently approved for cancer therapy as well as under different phases of clinical trials. Finally, we discuss the prospect of nanomedicine in cancer management.

Citing Articles

RNA-binding proteins as therapeutic targets in cancer.

Jungfleisch J, Gebauer F RNA Biol. 2025; 22(1):1-8.

PMID: 40016176 PMC: 11869776. DOI: 10.1080/15476286.2025.2470511.

The Use of Plant Viral Nanoparticles in Cancer Biotherapy-A Review.

Komane M, Kayoka-Kabongo P, Rutkowska D Viruses. 2025; 17(2).

PMID: 40006973 PMC: 11860677. DOI: 10.3390/v17020218.

Advancing Cancer Drug Delivery with Nanoparticles: Challenges and Prospects in Mathematical Modeling for In Vivo and In Vitro Systems.

Munyayi T, Crous A Cancers (Basel). 2025; 17(2).

PMID: 39857980 PMC: 11763932. DOI: 10.3390/cancers17020198.

Unlocking the potential of titanium dioxide nanoparticles: an insight into green synthesis, optimizations, characterizations, and multifunctional applications.

Ghareeb A, Fouda A, Kishk R, El Kazzaz W Microb Cell Fact. 2024; 23(1):341.

PMID: 39710687 PMC: 11665025. DOI: 10.1186/s12934-024-02609-5.

Docetaxel treatment together with CTLA-4 knockdown enhances reduction of cell viability and amplifies apoptosis stimulation of MCF-7 breast cancer cells.

Hosseinkhani N, Alipour S, Ghaffari Jolfayi A, Aghebati-Maleki L, Baghbani E, Alizadeh N Cytotechnology. 2024; 77(1):19.

PMID: 39676767 PMC: 11638433. DOI: 10.1007/s10616-024-00677-4.

References

Mulens-Arias V, Nicolas-Boluda A, Pinto A, Balfourier A, Carn F, Silva A . Tumor-Selective Immune-Active Mild Hyperthermia Associated with Chemotherapy in Colon Peritoneal Metastasis by Photoactivation of Fluorouracil-Gold Nanoparticle Complexes. ACS Nano. 2021; 15(2):3330-3348. DOI: 10.1021/acsnano.0c10276. View

Gonzalez-Vallinas M, Gonzalez-Castejon M, Rodriguez-Casado A, Ramirez de Molina A . Dietary phytochemicals in cancer prevention and therapy: a complementary approach with promising perspectives. Nutr Rev. 2013; 71(9):585-99. DOI: 10.1111/nure.12051. View

Dadfar S, Roemhild K, Drude N, von Stillfried S, Knuchel R, Kiessling F . Iron oxide nanoparticles: Diagnostic, therapeutic and theranostic applications. Adv Drug Deliv Rev. 2019; 138:302-325. PMC: 7115878. DOI: 10.1016/j.addr.2019.01.005. View

Wafa E, Geary S, Goodman J, Narasimhan B, Salem A . The effect of polyanhydride chemistry in particle-based cancer vaccines on the magnitude of the anti-tumor immune response. Acta Biomater. 2017; 50:417-427. PMC: 5316298. DOI: 10.1016/j.actbio.2017.01.005. View

Hu X, Zhang Y, Ding T, Liu J, Zhao H . Multifunctional Gold Nanoparticles: A Novel Nanomaterial for Various Medical Applications and Biological Activities. Front Bioeng Biotechnol. 2020; 8:990. PMC: 7438450. DOI: 10.3389/fbioe.2020.00990. View

Itoo A, Vemula S, Gupta M, Giram M, Kumar S, Ghosh B . Multifunctional graphene oxide nanoparticles for drug delivery in cancer. J Control Release. 2022; 350:26-59. DOI: 10.1016/j.jconrel.2022.08.011. View

Markwalter C, Pagels R, Wilson B, Ristroph K, Prudhomme R . Flash NanoPrecipitation for the Encapsulation of Hydrophobic and Hydrophilic Compounds in Polymeric Nanoparticles. J Vis Exp. 2019; (143). DOI: 10.3791/58757. View

Chauhan I, Yasir M, Verma M, Singh A . Nanostructured Lipid Carriers: A Groundbreaking Approach for Transdermal Drug Delivery. Adv Pharm Bull. 2020; 10(2):150-165. PMC: 7191226. DOI: 10.34172/apb.2020.021. View

Geim A . Graphene: status and prospects. Science. 2009; 324(5934):1530-4. DOI: 10.1126/science.1158877. View

10.

Lu G, Shang W, Deng H, Han Z, Hu M, Liang X . Targeting carbon nanotubes based on IGF-1R for photothermal therapy of orthotopic pancreatic cancer guided by optical imaging. Biomaterials. 2019; 195:13-22. DOI: 10.1016/j.biomaterials.2018.12.025. View

11.

Layek B, Haldar M, Sharma G, Lipp L, Mallik S, Singh J . Hexanoic acid and polyethylene glycol double grafted amphiphilic chitosan for enhanced gene delivery: influence of hydrophobic and hydrophilic substitution degree. Mol Pharm. 2014; 11(3):982-94. DOI: 10.1021/mp400633r. View

12.

Zhou W, Zhou Y, Chen X, Ning T, Chen H, Guo Q . Pancreatic cancer-targeting exosomes for enhancing immunotherapy and reprogramming tumor microenvironment. Biomaterials. 2020; 268:120546. DOI: 10.1016/j.biomaterials.2020.120546. View

13.

Sharma A . Chemoresistance in cancer cells: exosomes as potential regulators of therapeutic tumor heterogeneity. Nanomedicine (Lond). 2017; 12(17):2137-2148. DOI: 10.2217/nnm-2017-0184. View

14.

Kemp J, Kwon Y . Cancer nanotechnology: current status and perspectives. Nano Converg. 2021; 8(1):34. PMC: 8560887. DOI: 10.1186/s40580-021-00282-7. View

15.

Kim J, Shamul J, Shah S, Shin A, Lee B, Quinones-Hinojosa A . Verteporfin-Loaded Poly(ethylene glycol)-Poly(beta-amino ester)-Poly(ethylene glycol) Triblock Micelles for Cancer Therapy. Biomacromolecules. 2018; 19(8):3361-3370. PMC: 6249031. DOI: 10.1021/acs.biomac.8b00640. View

16.

Pugazhendhi A, Edison T, Karuppusamy I, Kathirvel B . Inorganic nanoparticles: A potential cancer therapy for human welfare. Int J Pharm. 2018; 539(1-2):104-111. DOI: 10.1016/j.ijpharm.2018.01.034. View

17.

Prato M, Kostarelos K, Bianco A . Functionalized carbon nanotubes in drug design and discovery. Acc Chem Res. 2007; 41(1):60-8. DOI: 10.1021/ar700089b. View

18.

DAcunto M, Cioni P, Gabellieri E, Presciuttini G . Exploiting gold nanoparticles for diagnosis and cancer treatments. Nanotechnology. 2021; 32(19):192001. DOI: 10.1088/1361-6528/abe1ed. View

19.

Yadav B, Chauhan M, Shekhar S, Kumar A, Mehata A, Nayak A . RGD-decorated PLGA nanoparticles improved effectiveness and safety of cisplatin for lung cancer therapy. Int J Pharm. 2023; 633:122587. DOI: 10.1016/j.ijpharm.2023.122587. View

20.

Altun I, Sonkaya A . The Most Common Side Effects Experienced by Patients Were Receiving First Cycle of Chemotherapy. Iran J Public Health. 2018; 47(8):1218-1219. PMC: 6123577. View